2 Ken Fisher Catalent Trades
Ken Fisher started to build up the position in Catalent in Q3 2019. Since then they sold 110 Thousand shares. The investor sold all their shares in Q4 2019 and doesn't own any shares in Catalent anymore.
News about Catalent Inc. and Ken Fisher
Novo Nordisk tapped Thermo Fisher to help make obesity drug Wegovy amid Catalent woes: Reuters
Novo Nordisk tapped Thermo Fisher to help make obesity drug Wegovy amid Catalent woes: Reuters aliu Wed, 08/23/2023 - 10:32
Biologics Contract Development and Manufacturing Organization(CDMO) Market: Know the Challenges and Trend Analysis | Thermo Fisher Scientific, Samsung BioLogics, AGC Biologics, Catalent
The Biologics Contract Development and Manufacturing Organization(CDMO) market research report added by Report Ocean, is an in-depth analysis of the latest ...
Global Contract Development & Manufacturing Organization (CDMO) Industry Outlook to 2026, Featuring Profiles of Key Players Lonza Group, Catalent, Thermo Fisher, Jubilant Pharmova, and More
DUBLIN, Sept. 20, 2021 /PRNewswire/ -- The "Global Contract Development and Manufacturing Organization (CDMO) Market Report and Forecast 2021-2026" report ha...
Clinical Trial Supplies Market worth $2.9 billion by 2026 - Leading Key Players are Thermo Fisher Scientific (US), Catalent Inc. (US), Parexel (US)
According to the new market research report "Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics, Distribution), Phases (I to IV)...